Resistant Hypertension: Questions and Contemporary Answers
The review presents the important problem of resistant hypertension. Its real prevalence is unknown. According to population studies and metaanalyzes of clinical studies, the prevalence of this most severe form of hypertension reaches 12-15% in the general population and 15-18% in clinical cohorts....
Main Authors: | V. I. Podzolkov, A. E. Bragina, K. K. Osadchiy |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2019-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2011 |
Similar Items
-
RATIONAL COMBINATIONS IN HYPERTENSION TREATMENT
by: V. I. Podzolkov, et al.
Published: (2016-01-01) -
The Study of the Fixed Dose Combination of Lisinopril with Prolonged Indopamide (FIXLINDA) with Daily Blood Pressure Monitoring and Diuresis in Hypertensive Patients
by: M. P. Savenkov, et al.
Published: (2019-09-01) -
Combined Therapy of Arterial Hypertension. The Opinion of a Clinical Pharmacologist
by: M. V. Zhuravleva, et al.
Published: (2020-09-01) -
Triple fixed-dose combination in the treatment of hypertension: the results of the Russian observational study TRICOLOR
by: Yu. A. Karpov, et al.
Published: (2020-11-01) -
Treatment of Hypertension: Is There a Place for Personalization of the Approach in Modern Recommendations?
by: V. I. Podzolkov, et al.
Published: (2020-07-01)